SEC Filing Details
Document Details
Form
Filing Date
Nov 4, 2026
Document Date
Nov 2, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
ARS Pharmaceuticals
Issuer
ARS PHARMACEUTICALS, INC.
Filer
SLEBIR JOHN L